Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. - Wikidata - awgldk - TriplyDB

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

http://www.wikidata.org/entity/Q44871721

about

Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients SPRINT: The Study Nephrologists Might Take With a Grain of Salt Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendations Mechanisms of arterial calcifications and consequences for cardiovascular function Does PTH offer additive value to ALP measurement in assessing CKD-MBD?Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials Phosphate control in end-stage renal disease: barriers and opportunities Calcium regulation and bone mineral metabolism in elderly patients with chronic kidney disease Pulmonary hypertension in renal disease: epidemiology, potential mechanisms and implications Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?Evidence for the prevention and treatment of stroke in dialysis patients Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis Hyperparathyroidism of Renal Disease Vascular calcification: When should we interfere in chronic kidney disease patients and how?Considerations and challenges in defining optimal iron utilization in hemodialysis Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease A New Data Analysis System to Quantify Associations between Biochemical Parameters of Chronic Kidney Disease-Mineral Bone Disease Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club.Cardiorenal Syndrome in Western Countries: Epidemiology, Diagnosis and Management Approaches.Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis.Cinacalcet versus standard treatment for chronic kidney disease: a systematic review and meta-analysis.Neurological complications in chronic kidney disease patients.Quantifying a rare disease in administrative data: the example of calciphylaxis Serum calcium and risk of migraine: a Mendelian randomization study Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients.Cardiovascular disease in CKD in 2012: moving forward, slowly but surely.Patient satisfaction with in-centre haemodialysis care: an international survey Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4 Periodontitis and early mortality among adults treated with hemodialysis: a multinational propensity-matched cohort study The use of fibroblast growth factor 23 testing in patients with kidney disease.When there will never be a randomized controlled trial.Vascular calcification in chronic kidney disease: role of disordered mineral metabolism.Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?Targets for parathyroid hormone in secondary hyperparathyroidism: is a "one-size-fits-all" approach appropriate? A prospective incident cohort study Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis.Reforming medicare's dialysis payment policies: implications for patients with secondary hyperparathyroidism Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends.Monitoring of hemodialysis quality-of-care indicators: why is it important?

P2860

Q24187385-62312296-304A-4650-B6AA-E3CE6B3439ED Q26745888-1405F60E-13A0-4187-9952-751E777B9B89 Q26781361-6F28168A-679E-416A-9B07-A63928C6770D Q26821993-857F7FA0-688A-43F8-BCAD-B417556785CD Q26830747-4D5929BD-A93F-4706-B638-1A83355C5AF7 Q26849298-B86258E9-7C0E-4521-A370-F9BDF9E26A57 Q26851487-B3B6C34E-ADC9-4B7D-B37A-19AD027CCC30 Q26853372-92D6403A-F2B9-4969-B95F-DF87730B633F Q26863412-C9655AC7-6C60-4D96-A77B-C35E37E6A4E8 Q26996772-F6E4EA1E-9599-4C0E-B688-7728098FE109 Q27002431-93EF4193-6507-48B9-A528-009FE93E0A87 Q27023274-D0958AAF-274A-41F5-AE17-91A815A9E170 Q27694667-BA515137-02E2-4D47-B798-2F1792624F92 Q28068593-9F6F93D4-3D82-4DD7-9F33-C869533E527B Q28071582-F73F2638-5934-4C27-B69F-21933B97EFCC Q28088564-BBBEEE3A-B287-4CF5-8ECA-0DB89A2CD41B Q28548561-10D423A4-BD29-47C4-B05B-84B892226410 Q28552810-A7A15F80-083B-4B3A-9FE3-FD31ED569448 Q30234797-A3DBD680-0521-4D59-BEFA-3D0DEA7A405D Q30235173-9CD20B98-CECE-47C5-8280-BD6EDBF902BC Q30235589-77F7F895-64C2-4E80-8979-F136B2819A8A Q30250264-E033FB64-C542-41D2-9464-C063D2F8214A Q30251450-E198A6C6-458B-440A-B746-5B165C0D847A Q30252095-373D300F-ED67-4643-8059-D022156A01D5 Q30836782-13398B9D-D653-44E7-8852-109718EF09CD Q33614592-A5A25568-A6AF-46A4-8627-8966B6B80407 Q33625482-2823C862-0CFE-4C69-AEBD-C6BF21A03846 Q33682243-B42C0D2E-1C0E-4FAC-9CD9-C955A5CD4FE2 Q33691308-7BE1CAF9-B7D6-4794-A37C-9E0B31001EE1 Q33715785-6D24F29F-72B8-449C-94C1-63480B5B85AE Q33716655-FE4AC90F-378F-456F-9532-FC227B749490 Q33835743-A96E5BFE-6AF8-4811-AE1C-430A93086227 Q33894084-1768B3C6-EB40-40B4-B7ED-EA3AADE9A6D7 Q34037021-A8973608-1C54-46ED-BF80-BDAF176BE1D3 Q34403555-23BA62ED-E5F8-438D-8A05-82C6CB9D2891 Q34538433-F08E7FF1-FBEA-4D33-BB6C-54B969A9F912 Q34610602-A444B717-0CEB-4937-9721-E52B30791398 Q34623082-3886D93A-5E15-4410-854F-ED9A0C496A74 Q34704916-1D5ADE11-5363-403C-81D4-AE1654BDAA54 Q34738880-020D6F34-B614-4533-A08F-EF102461F947

P2860

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

http://www.wikidata.org/entity/Q44871721

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

@en

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

@nl

type

label

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

@en

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

@nl

prefLabel

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

@en

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

@nl

P1433

Q44871721-D85C38CC-75CC-4B1E-A7B4-75556444090D

P1476

Q44871721-9A622207-4D69-4986-94E2-AA64B679D6AD

P2093

Q44871721-0F01E0CD-71FE-4FC8-815D-4E16C9C2038D

Q44871721-1CD86B4C-FB3E-4FEA-BE3C-2C5E59EC6954

Q44871721-1F83A243-A430-4FA2-8F47-8A66AD8E5872

Q44871721-27D41F14-DF34-4EA0-BF26-9925B4CBA588

Q44871721-31F1CD91-962F-483F-AAB8-89204CE02F6E

Q44871721-384599D3-368C-4BBE-A6BE-02C270BF72D0

Q44871721-496EE230-F84C-4607-A9CA-279EF2BC73E3

Q44871721-748A0C91-F61D-48D9-BDAA-4F7DA2633F88

Q44871721-7F2AFA0B-D5D6-4CEB-98A1-8A57ED0738A9

Q44871721-854EB471-A39D-4117-83F6-C3589E5049C6

P304

Q44871721-744699D4-42F2-4690-8181-2DD965E6BFCE

P31

Q44871721-9B77032E-5AE0-4205-A59A-3D5B84A912DB

P356

Q44871721-EAA7432A-A87B-46D6-9F39-345E568CDF53

P407

Q44871721-49E589A0-544F-4CC4-A3AC-6618CFFDF264

P433

Q44871721-52D4B7F9-D592-48D3-A519-9FD9E277DAC2

P478

Q44871721-9A6F4A78-5F11-42DA-87E0-8004E3AD7EAE

P50

Q44871721-1B51F911-8BAC-43F0-8F14-B19092A8211D

P577

Q44871721-7DF2D38A-1695-4112-A6CA-A0393302EB4A

P698

Q44871721-391981B6-E0F0-42E1-8083-9A788226AD5C

P921

Q44871721-02F19004-418D-4D5C-9C71-AD418E94BD40

Q44871721-04B1BAB7-37E4-4320-8AD9-551EFD994A9F

P356

P1433

The New England Journal of Medicine

P1476

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

@en

P2093

Charles A Herzog

http://www.w3.org/2001/XMLSchema#string

David C Wheeler

http://www.w3.org/2001/XMLSchema#string

EVOLVE Trial Investigators

http://www.w3.org/2001/XMLSchema#string

Geoffrey A Block

http://www.w3.org/2001/XMLSchema#string

Gerard M London

http://www.w3.org/2001/XMLSchema#string

Glenn M Chertow

http://www.w3.org/2001/XMLSchema#string

Jürgen Floege

http://www.w3.org/2001/XMLSchema#string

Marie-Louise Trotman

http://www.w3.org/2001/XMLSchema#string

Patrick S Parfrey

http://www.w3.org/2001/XMLSchema#string

Ricardo Correa-Rotter

http://www.w3.org/2001/XMLSchema#string

P304

2482-2494

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1205624

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

367

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth W Mahaffey

P577

2012-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23121374

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease